Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

Jaime Feliu,Pablo Borrega,A. León,Luis López Gómez,Miguel Ángel Cauqui López,Javier de Castro,Cristóbal Belda Iniesta,J. Barriuso,Virginia Martínez,Manuel González Barón

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

2011

Jaime Feliu
Pablo Borrega
A. León
Luis López Gómez
Miguel Ángel Cauqui López
Javier de Castro
Cristóbal Belda Iniesta
J. Barriuso
Virginia Martínez
Manuel González Barón

Purpose To evaluate the feasibility, toxicity and efficacy of the combination regimen consisting of gemcitabine-FDR infusion plus erlotinib, in ACP patients.

Keywords:

Phases of clinical research
Regimen
Pancreatic cancer
Erlotinib
Progressive disease
Gemcitabine
Survival rate
Oncology
Medicine
Internal medicine
Toxicity
Pharmacology
Neutropenia
Rash
Gastroenterology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations